Human medicines European public assessment report (EPAR): Invanz, ertapenem, Date of authorisation: 18/04/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Obizur, susoctocog alfa, Date of authorisation: 11/11/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 59, Status: Authorised

List of medicines currently in PRIME scheme

Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 10-13 November 2025

Antimicrobial resistance in human medicine

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Date of authorisation: 14/08/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 6, Status: Authorised

Regulatory Procedure Management in IRIS roadmap